“The results from these Phase 3 trials support the clinical benefit of PT027, an albuterol/budesonide rescue inhaler, which has the potential to be a first-in-class treatment approach that can ...

Teva noted it is the first and only digital rescue inhaler indicated in patients four years or older for the treatment or prevention of bronchospasm who have reversible obstructive airway disease ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...

He added: "Deaths are often caused by patients not taking their preventer steroid medication and over-using their blue rescue inhaler, so therefore if we can track patients use of the correct ...

enhancing patient access to safe and affordable medicines delivered via inhalers, including both maintenance and rescue inhalers.” Teva will make two inhaler products available through this ...

"The aim of this program is to help address an unmet need in underserved communities nationwide, enhancing patient access to safe and affordable medicines delivered via inhalers, including both ...